Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema

Purpose. To access the choroidal structural changes of posterior subtenon triamcinolone acetonide (PSTA) injection in eyes with refractory diabetic macular edema (DME). Methods. Patients with refractory DME were enrolled and followed for 4 weeks after switching to PSTA injection. All patients underw...

Full description

Saved in:
Bibliographic Details
Main Authors: Bing Liu, Guangfeng Ma, Jing Hou, Chenyang Cong
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2022/6882607
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550403171942400
author Bing Liu
Guangfeng Ma
Jing Hou
Chenyang Cong
author_facet Bing Liu
Guangfeng Ma
Jing Hou
Chenyang Cong
author_sort Bing Liu
collection DOAJ
description Purpose. To access the choroidal structural changes of posterior subtenon triamcinolone acetonide (PSTA) injection in eyes with refractory diabetic macular edema (DME). Methods. Patients with refractory DME were enrolled and followed for 4 weeks after switching to PSTA injection. All patients underwent spectral-domain optical coherence tomography with enhanced depth imaging, and the choroidal images were binarized into the luminal area and total choroidal area. Subfoveal choroidal thickness (SFCT) and choroidal vascularity index (CVI) were evaluated before and after switching treatments. Results. After switching to PSTA treatment, the final best-corrected visual acuity and central subfield thickness in eyes with refractory DME were significantly improved compared to the baseline values (P=0.002 and P<0.001, respectively). Both the SFCT and CVI decreased during the follow-up period, and significant decreases were observed at 4-week follow-up (P<0.001 and P=0.012, respectively). The linear regression analysis showed a significant correlation between the baseline SFCT and the final visual outcomes (P=0.047). Conclusions. The alterations of SFCT and CVI in this study suggest that the choroidal vasculature is involved in the pathogenesis of refractory DME and could be affected by PSTA treatment. SFCT rather than CVI may be a prognostic biomarker for eyes with refractory DME.
format Article
id doaj-art-226802c94c6d4ab2be572d822232a0e1
institution Kabale University
issn 2090-0058
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-226802c94c6d4ab2be572d822232a0e12025-02-03T06:06:53ZengWileyJournal of Ophthalmology2090-00582022-01-01202210.1155/2022/6882607Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular EdemaBing Liu0Guangfeng Ma1Jing Hou2Chenyang Cong3Department of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyAffiliated Eye Hospital of Shandong University of Traditional Chinese MedicinePurpose. To access the choroidal structural changes of posterior subtenon triamcinolone acetonide (PSTA) injection in eyes with refractory diabetic macular edema (DME). Methods. Patients with refractory DME were enrolled and followed for 4 weeks after switching to PSTA injection. All patients underwent spectral-domain optical coherence tomography with enhanced depth imaging, and the choroidal images were binarized into the luminal area and total choroidal area. Subfoveal choroidal thickness (SFCT) and choroidal vascularity index (CVI) were evaluated before and after switching treatments. Results. After switching to PSTA treatment, the final best-corrected visual acuity and central subfield thickness in eyes with refractory DME were significantly improved compared to the baseline values (P=0.002 and P<0.001, respectively). Both the SFCT and CVI decreased during the follow-up period, and significant decreases were observed at 4-week follow-up (P<0.001 and P=0.012, respectively). The linear regression analysis showed a significant correlation between the baseline SFCT and the final visual outcomes (P=0.047). Conclusions. The alterations of SFCT and CVI in this study suggest that the choroidal vasculature is involved in the pathogenesis of refractory DME and could be affected by PSTA treatment. SFCT rather than CVI may be a prognostic biomarker for eyes with refractory DME.http://dx.doi.org/10.1155/2022/6882607
spellingShingle Bing Liu
Guangfeng Ma
Jing Hou
Chenyang Cong
Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema
Journal of Ophthalmology
title Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema
title_full Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema
title_fullStr Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema
title_full_unstemmed Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema
title_short Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema
title_sort choroidal structural changes of posterior subtenon triamcinolone acetonide injection in eyes with refractory diabetic macular edema
url http://dx.doi.org/10.1155/2022/6882607
work_keys_str_mv AT bingliu choroidalstructuralchangesofposteriorsubtenontriamcinoloneacetonideinjectionineyeswithrefractorydiabeticmacularedema
AT guangfengma choroidalstructuralchangesofposteriorsubtenontriamcinoloneacetonideinjectionineyeswithrefractorydiabeticmacularedema
AT jinghou choroidalstructuralchangesofposteriorsubtenontriamcinoloneacetonideinjectionineyeswithrefractorydiabeticmacularedema
AT chenyangcong choroidalstructuralchangesofposteriorsubtenontriamcinoloneacetonideinjectionineyeswithrefractorydiabeticmacularedema